Black Diamond Therapeutics Inc. (NASDAQ: BDTX) Stock Information | RedChip

Black Diamond Therapeutics Inc. (NASDAQ: BDTX)


$2.1500
-0.0400 ( +0.47% ) 287.8K

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Market Data


Open


$2.1500

Previous close


$2.1900

Volume


287.8K

Market cap


$125.34M

Day range


$2.1050 - $2.3640

52 week range


$2.1050 - $7.6600

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Feb 15, 2024
4 Insider transactions 1 Feb 15, 2024
4 Insider transactions 1 Feb 15, 2024
8-k 8K-related 12 Jan 18, 2024
8-k 8K-related 57 Jan 04, 2024
4 Insider transactions 1 Dec 15, 2023
4 Insider transactions 1 Dec 15, 2023
8-k 8K-related 14 Dec 13, 2023

Latest News